Pulmonary rehabilitation in interstitial lung disease

Chest

Volumn 135, Issue 2, 2009, Pages 442-447

  Ferreira, Alicia ^a   Garvey, Chris ^b   Connors, Gerilynn L ^c   Hilling, Lana ^d   Rigler, Julia ^b   Farrell, Susan ^c   Cayou, Cindy ^d   Shariat, Cyrus ^e   Collard, Harold R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Seton Medical Center   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

^d John Muir Health   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Dyspnea; Functional status; Pulmonary fibrosis; Pulmonary rehabilitation; Treatment

Indexed keywords

6 MIN WALK TEST; AGED; ARTICLE; BORG SCORE; DYSPNEA; FEMALE; FUNCTION TEST; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY REHABILITATION; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 60249091063     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1458     Document Type: Article

References (32)

1. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173:1390-1413
2. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 18:CD003793
3. Laviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 2008; 63:115-121
4. Niederman MS, Clemente PH, Fein AM, et al. Benefits of a multidisciplinary pulmonary rehabilitation program: improvements are independent of lung function. Chest 1991; 99:798-804
5. Ries AL, Make BJ, Lee SM, et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 2005; 128:3799-3809
6. Verrill D, Barton C, Beasley W, et al. The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 2005; 128:673-683
7. Markovitz GH, Cooper CB. Exercise and interstitial lung disease. Curr Opin Pulm Med 1998; 4:272-280
8. Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005; 127:284-294
9. Baddini-Martinez JA, Martinez TY, Lovetro-Galhardo FP, et al. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit 2002; 8:CR405-410
10. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109:1566-1576
11. Schwarz M, King TE Jr. Physiology of interstitial lung disease. In: Schwarz M, King TE Jr. Interstitial lung disease. 4th ed. Hamilton, ON: BC Decker, 2003; 54-74
12. Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63:549-554
13. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13:394-399
14. Ferreira G, Feuerman M, Spiegler P. Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2006; 26:54-60
15. Jastrzebski D, Gumola A, Gawlik R, et al. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol 2006; 57(suppl):139-148
16. Naji NA, Connor MC, Donnelly SC, et al. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil 2006; 26:237-243
17. Foster S, Thomas HM III. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141:601-604
18. Kupferberg DH, Kaplan RM, Slymen DJ, et al. Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. J Cardiopulm Rehabil 2005; 25:370-377
19. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005; 2:105-110
20. Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401
21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117
22. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155:1278-1282
23. Collard HR, King TE Jr, Bartelson BB, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168:538-542
24. King TE Jr, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164:1171-1181
25. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-180
26. Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:659-664
27. Gerardi DA, Lovett L, Benoit-Connors ML, et al. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 1996; 9:431-435
28. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28-33
29. Collard HR, Loyd JE, King TE Jr, et al. Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med 2007; 101:2011-2016
30. Crouch R, MacIntyre NR. Pulmonary rehabilitation of the patient with nonobstructive lung disease. Respir Care Clin N Am 1998; 4:59-70
31. O'Keeffe ST, Lye M, Donnellan C, et al. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998; 80:377-382
32. Eaton T, Young P, Milne D, et al. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171:1150-1157